Hauwermeiren Timothy Van's Net Worth

$0

Estimate Recalculated Jul 12, 2024 03:56PM EST

Who is Hauwermeiren Timothy Van?

Hauwermeiren Timothy Van does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include iTeos Therapeutics, Inc., and RayzeBio, Inc..

SEC CIK

Hauwermeiren Timothy Van's CIK is 0001816206

Past Insider Trading and Trends

2020 was Hauwermeiren Timothy Van's most active year for acquiring shares with 2 total transactions. Hauwermeiren Timothy Van's most active month to acquire stocks was the month of May. 2023 saw Hauwermeiren Timothy Van paying a total of $0.00 for 22,383 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

iTeos Therapeutics, Inc. (ITOS) Snapshot price: $9.985

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 11
Form 4
—
0
—
—
0
Jun 13
Form 4
—
0
—
—
0
Jun 9
Form 4
—
0
—
—
0
Jun 17
Form 4/A
—
0
—
—
0
Jul 23
Form 4
—
0
—
—
0
Jul 23
Form 3
—
0
—
—
0
No matching records found

RayzeBio, Inc. (RYZB) Snapshot price: $62.18

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 26
Form 4
—
0
—
—
0
Nov 1
Form 3
—
0
—
—
0
No matching records found

Lexeo Therapeutics, Inc. (LXEO) No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 5
Form 3
—
0
—
—
0
No matching records found